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Despite well-documented negative effects of smoking, many individuals continue to 
smoke. Anxiety and depression are associated with poorer cessation outcomes. Three 
transdiagnostic factors may explain the anxiety/depression-smoking link: anxiety sensitivity 
(AS), distress tolerance (DT), anhedonia (Anh; Leventhal & Zvolensky, 2015). It therefore 
follows that changing AS, DT, and Anh could aid cessation efforts. Thus, the current study 
tested the efficacy of hatha yoga for reducing craving, smoking, AS, and Anh and increasing 
DT, and whether anxiety/depression moderates these relationships. Participants were 55 
community-recruited smokers (62% male, 71% non-Hispanic White, Mage = 28.16) motivated 
to reduce or quit smoking. We randomized participants to one session of hatha yoga (n = 25) 
or wellness control (n = 30) on their intervention day (when they planned to begin to reduce 
or quit smoking). We asked them to use the provided intervention materials daily for a week. 
Hatha yoga was associated with less post-intervention craving but not fewer follow-up 
cigarettes per day than control. Anxiety/depression did not moderate these relationships. 
Hatha yoga was associated with less follow-up AS than the control condition. We found a 
significant Condition x Anxiety/Depression interaction, such that among participants with 
high anxiety/depression, those in the hatha yoga condition reported less follow-up AS than 
those in the control condition. Hatha yoga did not impact DT or Anh. In sum, hatha yoga 
acutely reduces craving but does not impact smoking. Hatha yoga decreased AS, especially 
among individuals with higher anxiety/depression, a group at particular risk for poorer 




The negative health consequences of cigarette smoking (e.g., cardiovascular disease, 
respiratory illness, cancer) have been well documented over the past several decades (Ezzati, 
Henley, Lopez, & Thun, 2005; Ezzati, Henley, Thun, & Lopez, 2005; US Department of 
Health and Human Services, 1982, 1983, 1984). Potentially in part due to greater public 
understanding of these health-related consequences, along with increased restrictions on 
smoking (per Pierce, White, & Emery, 2012), smoking rates among adults in the United 
States have declined from 20.9% in 2005 to 15.5% in 2016 (Centers for Disease Control and 
Prevention, 2018). Despite this decline, smoking remains the leading cause of preventable 
disease and death in the United States, with more than 480,000 premature deaths attributable 
to smoking occurring each year (Centers for Disease Control and Prevention, 2018). 
According to the Centers for Disease Control and Prevention, during 2015, 55.4% of smokers 
made a quit attempt that lasted longer than one day and 7.4% of smokers quit smoking during 
the previous year (Centers for Disease Control and Prevention, 2017c). Moreover, three-
fourths of smokers who underwent an unaided quit attempt lapsed within the first week of the 
quit attempt (Langdon, Farris, Øverup, & Zvolensky, 2016). Similarly, 75.5% of smokers 
who underwent a one-session relaxation intervention smoked during the two weeks following 
the intervention (Dickson-Spillmann, Haug, & Schaub, 2013). These findings suggest that 
many individuals attempt to quit smoking, the majority of individuals smoke within the first 
couple weeks of their cessation attempts, and few individuals succeed in ultimately quitting 
smoking. This has led to a call for research to develop more targeted interventions for 




Anxiety, Depression, and Smoking 
One group at risk for higher rates of smoking cessation failure are individuals with 
anxiety and depression. Rates of current smoking are higher among individuals with lifetime 
anxiety and depressive disorder diagnoses (35.9%-54.6%) than individuals without lifetime 
psychiatric diagnoses (22.5%; Lasser et al., 2000). Further, the 12-month prevalence rates of 
anxiety disorders (22%) and major depressive disorder (16.6%) were at least twice as high 
among smokers with nicotine dependence (i.e., a maladaptive pattern of nicotine use that is 
typically associated with symptoms such as tolerance, withdrawal, and using nicotine despite 
it causing or exacerbating physical or psychological problems; American Psychiatric 
Association, 1994) than among the general population (11.1% and 7.1%, respectively; Grant, 
Hasin, Chou, Stinson, & Dawson, 2004). These rates may continue to increase as smokers 
without such diagnoses are better able to quit, while smokers with these problems remain 
smoking (i.e., the hardening theory; Hughes, 1999; Hughes, 2011).  
Smokers with anxiety and depressive disorders have demonstrated poorer smoking 
cessation outcomes. To illustrate, among over 1,500 smokers who underwent an aided 
smoking cessation attempt, having a lifetime anxiety or depressive disorder diagnosis was 
associated with lower abstinence rates eight weeks and six months post-quit (Piper et al., 
2010). Similarly, past major depression was associated with 17% lower odds of short-term 
abstinence and 19% lower odds of long-term abstinence according to a recent meta-analytic 
study (Hitsman et al., 2013). Additionally, among treatment-seeking smokers, baseline 
depressive symptoms were associated with increased odds of relapse at days one, seven, and 
14 post-quit (Zvolensky, Stewart, Vujanovic, Gavric, & Steeves, 2009). Further, treatment-
seeking smokers who met criteria for a lifetime anxiety or depressive disorder reported 
significantly more prior quit attempts and endorsed using significantly more cessation 
strategies than individuals without a lifetime anxiety or depressive disorder diagnosis 
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(Zvolensky, Farris, Leventhal, Ditre, & Schmidt, 2015). Taken together, smokers who have 
anxiety and depression may need additional interventions strategies to successfully quit 
smoking. 
Why might these smokers have poorer cessation outcomes? One possible explanation 
is they tend to have more severe nicotine dependence. For example, among smokers who 
were interested in quitting smoking, those with anxiety disorders reported higher levels of 
nicotine dependence (e.g., more difficulty refraining from smoking in places where smoking 
is forbidden, smoking despite being ill; Heatherton, Kozlowski, Frecker, & Fagerström, 
1991) than smokers without anxiety disorders (Piper, Cook, Schlam, Jorenby, & Baker, 
2011). Further, adolescent smokers who endorsed high levels of anxiety/depression 
symptoms at baseline were significantly more likely to have nicotine dependence during 
young adulthood than adolescents who endorsed low baseline levels of anxiety/depression 
symptoms, even after accounting for the variance attributable to gender and baseline 
substance use (McKenzie, Olsson, Jorm, Romaniuk, & Patton, 2010).   
Considering that both anxiety and depression are related to poorer smoking cessation 
outcomes, it follows that transdiagnostic factors may play a role in this relationship. 
Transdiagnostic factors are core dispositional traits that reflect maladaptive responses to 
affective states that underlie multiple types of psychopathology. Indeed, Leventhal and 
Zvolensky (2015) recently proposed that three transdiagnostic factors underlie the 
anxiety/depression-smoking relationship: (a) anxiety sensitivity (AS), (b) distress tolerance 
(DT), and (c) anhedonia (Anh). Leventhal and Zvolensky posit that these transdiagnostic 
“reactive” factors influence one’s response to emotion states, which may include a variety of 




Transdiagnostic Factors and Smoking 
Anxiety sensitivity. AS is a transdiagnostic reactive factor that reflects a fear of 
anxiety-related sensations (e.g., elevated heart rate, dizziness) due to beliefs that these 
sensations have detrimental physical, cognitive, or social consequences (McNally, 2002). For 
example, someone with high AS who experiences heart palpitations may believe the 
sensation is a sign of a heart attack, whereas an individual with low AS may believe the 
sensation is unpleasant, but benign. AS is stable (Rodriguez, Bruce, Pagano, Spencer, & 
Keller, 2004), yet malleable (e.g., Schmidt et al., 2007), and is related to but distinct from 
trait anxiety (Taylor, Koch, & Crockett, 1991). AS amplifies the anxiety response (Reiss, 
1991). In other words, when high-AS individuals become anxious, they become anxious 
about a feared stimulus and about their own anxiety, which further exacerbates their anxiety 
reaction (as proposed by Collimore & Asmundson, 2014).  
 The role of AS in the etiology and maintenance of panic disorder has been the subject 
of a large body of research (for review see McNally, 2002). In addition to AS’s influence on 
panic psychopathology, it is associated with numerous other psychiatric disorders, including 
social anxiety disorder, generalized anxiety disorder (Deacon & Abramowitz, 2006), and 
major depressive disorder (Otto, Pollack, Fava, Uccello, & Rosenbaum, 1995). Illustrating 
AS’s transdiagnostic nature and importance as a mechanism of change in the treatment of 
anxiety and depressive disorders, AS mediated symptom improvement among individuals 
who underwent a transdiagnostic treatment for anxiety and depressive disorders (i.e., the 
Unified Protocol; Boswell et al., 2013).  
Anxiety sensitivity and smoking cessation. AS is related to poorer cessation 
outcomes among smokers who are attempting to quit smoking. For example, among smokers 
who underwent an aided quit attempt, greater AS was robustly related to a greater risk of 
lapsing at days one, seven, and 14 post-quit after controlling for gender, nicotine dependence, 
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withdrawal symptom severity, and baseline anxiety/depression (Zvolensky et al., 2009). 
Greater AS was also associated with a greater risk of lapsing during the first week after a quit 
attempt among smokers with depression (Brown, Kahler, Zvolensky, Lejuez, & Ramsey, 
2001). Additionally, among smokers who underwent nicotine replacement therapy (NRT)-
aided cognitive behavioral therapy (CBT) for smoking cessation, smokers who maintained 
high levels of AS from pre-treatment to one-month post-treatment had a significantly greater 
risk of lapse and relapse compared to smokers who evidenced a significant reduction in AS 
(Assayag, Bernstein, Zvolensky, Steeves, & Stewart, 2012). Further, adult daily smokers with 
higher levels of AS were more likely to report having experienced early (i.e., within one 
week) smoking relapse in two separate investigations (Zvolensky et al., 2007; Zvolensky, 
Bonn-Miller, Bernstein, & Marshall, 2006). Moreover, AS significantly predicted greater 
odds of study dropout prior to attending the scheduled quit day appointment among smokers 
recruited to participate in a self-guided quit attempt (Langdon, Farris, Hogan, Grover, & 
Zvolensky, 2016). In sum, these results suggest that AS plays an important role in the early 
stages of smoking cessation.  
Anxiety sensitivity and smoking-related risk factors. AS may be related to poorer 
cessation outcomes due to its associations with other smoking-related risk factors such as 
nicotine dependence, withdrawal symptoms, and smoking outcome expectancies. To 
illustrate, greater AS was related to more severe nicotine dependence in several studies 
(Farris, Leventhal, Schmidt, & Zvolensky, 2015; Zvolensky, Farris, Schmidt, & Smits, 2014). 
Further, the presence of an anxiety or depressive disorder diagnosis was indirectly related to 
higher levels of nicotine dependence, greater perceived barriers to cessation, and greater 
severity of problematic symptoms during past quit attempts via AS (Zvolensky, Farris, 
Leventhal, & Schmidt, 2014). Additionally, AS mediated the relationship between trait worry 
and several smoking-related variables (e.g., nicotine dependence) after controlling for 
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relevant factors (e.g., negative affect, alcohol use) among treatment-seeking smokers (Olvera 
et al., 2015). Taken together, greater AS is related to several smoking-related risk factors, 
including more severe nicotine dependence, which may at least partially account for the 
relationship between anxiety/depression and nicotine dependence.  
AS is related to more severe withdrawal symptoms and craving. Among treatment-
seeking smokers, AS was associated with more severe nicotine withdrawal during prior quit 
attempts and prior to quit day (Farris, Leventhal, et al., 2015). Further, among smokers who 
underwent an AS reduction-smoking cessation intervention (Schmidt, Raines, Allan, & 
Zvolensky, 2016), AS moderated the relationship between pre-quit reductions in AS and quit 
day craving, such that smokers with high AS who demonstrated less reductions in AS prior to 
quitting reported the highest levels of craving on quit day (Bakhshaie et al., 2016). Greater 
AS was also incrementally related to more severe withdrawal symptoms and craving after 
accounting for the variance attributable to gender, nicotine dependence, and depression 
among non-treatment-seeking smokers who were deprived of nicotine for 16 hours 
(Zvolensky, Farris, Guillot, & Leventhal, 2014). Greater AS was associated with slower 
decreases in withdrawal symptoms among smokers who underwent an aided cessation 
attempt (Johnson, Stewart, Rosenfield, Steeves, & Zvolensky, 2012). These results suggest 
that greater AS is associated with more severe withdrawal symptoms and individuals with 
higher levels of AS may continue to experience withdrawal symptoms for longer once 
cessation has occurred, suggesting that individuals with higher AS may benefit from 
additional cessation strategies, particularly strategies that could reduce AS.  
In line with negative reinforcement models of substance use (e.g., Baker, Brandon, & 
Chassin, 2004; Conger, 1956; Khantzian, 1997) which posit that individuals use substances 
in an attempt to relieve unpleasant physical and/or emotional states, AS was related to 
negative reinforcement smoking expectancies (e.g., beliefs that smoking will reduce negative 
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affect) and motives among treatment-seeking (Battista et al., 2008; Brown et al., 2001; Garey 
et al., 2016; Zvolensky, Farris, Schmidt, et al., 2014), college student (Zvolensky et al., 
2004), and community-recruited (Gonzalez, Zvolensky, Vujanovic, Leyro, & Marshall, 2008; 
Gregor, Zvolensky, McLeish, Bernstein, & Morissette, 2008; Guillot, Pang, & Leventhal, 
2014; Leyro, Zvolensky, Vujanovic, & Bernstein, 2008) smokers. These findings suggest that 
individuals with high AS may smoke to cope with negative affect associated with AS or to 
avoid feared withdrawal symptoms that are synonymous with anxiety symptoms (e.g., 
sweating, nausea). This may make it more difficult for these individuals to quit smoking, 
potentially due to a lack of coping skills to manage such states.  
In partial support of this hypothesis, smoking reduced anxiety in high AS smokers in 
a stressful situation (i.e., giving a speech) but not a non-stressful situation (Evatt & Kassel, 
2010). Ecological momentary assessment demonstrated that AS interacted with negative 
affect to predict subsequent smoking, such that individuals with high AS were more likely to 
smoke on days they experienced high levels of negative affect (Langdon, Farris, Øverup, et 
al., 2016). In sum, greater AS is related to poorer smoking cessation outcomes and may be 
one factor linking anxiety/depression with other smoking-related factors (e.g., nicotine 
dependence, withdrawal symptoms). 
Distress tolerance. DT is another transdiagnostic reactive factor, which has been 
conceptualized as both: (1) the perceived capacity to withstand negative emotional states and 
(2) the objective behavioral capacity to withstand negative internal states elicited by some 
type of a stressor. Thus, DT has recently been defined as a higher-order construct that reflects 
one’s ability to withstand any aversive experience (e.g., negative emotional states, physical 
sensations that provoke negative affect; Leventhal & Zvolensky, 2015). DT is relatively 
stable (Simons & Gaher, 2005), yet malleable (e.g., Medina, Hopkins, Powers, Baird, & 
Smits, 2015). Individuals with lower DT (i.e., less able to tolerate distress) tend to respond in 
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maladaptive ways to distress (e.g., avoidance, substance use; Jeffries, McLeish, Kraemer, 
Avallone, & Fleming, 2016; Simons & Gaher, 2005).  
Lower DT is robustly related to several forms of anxiety, including social anxiety, 
trait worry, and panic after controlling for other theoretically relevant factors (e.g., AS, 
gender; Keough, Riccardi, Timpano, Mitchell, & Schmidt, 2010; Norr et al., 2013). 
Individuals with anxiety disorders have lower levels of DT (Michel, Rowa, Young, & 
McCabe, 2016) than non-clinical samples (Keough et al., 2010; Norr et al., 2013). Further, 
lower DT was related to depressive symptoms among individuals with anxiety disorders 
(Michel et al., 2016), persons with major depressive disorder (Williams, Thompson, & 
Andrews, 2013), and adults who use substances (Buckner, Keough, & Schmidt, 2007; Gorka, 
Ali, & Daughters, 2012). Taken together, lower DT is associated with both anxiety and 
depression among a heterogeneous population.  
Distress tolerance and smoking cessation. DT appears to play a role in poorer 
smoking cessation outcomes. Compared to smokers who had one or more sustained quit 
attempts for three months or longer, smokers who had never sustained a quit attempt for more 
than 24 hours exhibited lower behavioral DT (Brown, Lejuez, Kahler, & Strong, 2002). 
Among smokers who were attempting to quit smoking, lower baseline behavioral DT was 
related to greater risk of lapse and relapse in several prospective studies (Abrantes et al., 
2008; Brandon et al., 2003; Brown et al., 2009; Cameron, Reed, & Ninnemann, 2013; Hajek, 
Belcher, & Stapleton, 1987). Results from these studies suggest that individuals with lower 
levels of DT have more difficulty quitting smoking. It may be that some indices of behavioral 
DT are more related to smoking outcomes than others. Results concerning the impact of 
behavioral DT on smoking outcomes are somewhat inconsistent, even within individual 
studies (e.g., Cameron et al., 2013), with some indices of behavioral DT (i.e., Paced Auditory 
Serial Addition Task [PASAT]) being associated with poorer cessation outcomes and some 
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not (i.e., Mirror Tracing Persistence Task). Behavioral DT as measured by the breath-holding 
(BH) task (Hajek et al., 1987) has been most commonly used in the smoking literature 
(Leventhal & Zvolensky, 2015) and may be an ideal measurement of DT given that it is easy 
to administer and lower DT as measured by BH duration was associated with greater risk of 
poorer smoking cessation outcomes in several studies (Brown et al., 2002; Brown et al., 
2009; Hajek et al., 1987). Further, DT as measured by the PASAT was related to quicker 
relapse during a quit attempt (Cameron et al., 2013), demonstrating its utility in smoking 
cessation research.   
Distress tolerance and smoking-related risk factors. Lower DT is related to nicotine 
dependence and negative reinforcement-motivated smoking. To illustrate, among non-
treatment-seeking smokers, lower perceived DT was correlated with more severe nicotine 
dependence in several studies (Kraemer, McLeish, Jeffries, Avallone, & Luberto, 2013; 
Leyro, Bernstein, Vujanovic, McLeish, & Zvolensky, 2011). Similarly, among adult smokers, 
less perceived DT was incrementally related to greater severity of nicotine dependence after 
controlling for anxiety/depression symptoms (Trujillo et al., 2015) and among non-treatment-
seeking smokers, lower behavioral DT was correlated with more severe nicotine dependence 
(Brandon et al., 2003). Consistent with negative reinforcement models of substance use (e.g., 
Baker, Piper, McCarthy, Majeskie, & Fiore, 2004), perceived DT correlated with negative 
reinforcement smoking expectancies (Leyro et al., 2011) and was incrementally related to 
negative reinforcement-motivated smoking after accounting for the variance attributable to 
anxiety and depression symptoms (Trujillo et al., 2015).  
Among smokers who participated in a smoking cessation attempt, daily life hassles 
were associated with daily craving (measured using ecological momentary assessment) 
among smokers who exhibited low baseline behavioral DT (Volz et al., 2014), suggesting 
that smokers with low DT may desire to smoke more during stressful situations. In light of 
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these findings, smokers with lower DT may be more prone to smoke while distressed in an 
attempt to terminate their distress, which may place them at greater risk for lapse and relapse 
when facing symptoms characteristic of nicotine withdrawal (e.g., increased anxiety). 
Importantly, lower DT was associated with smoking-related factors (e.g., severity of nicotine 
dependence) above and beyond the effects of anxiety/depression symptoms (Trujillo et al., 
2015), making it an ideal transdiagnostic explanatory mechanism of the anxiety/depression-
smoking relationship.  
Anhedonia. Anh is another transdiagnostic reactive factor that reflects a reduced 
capacity to experience pleasure from commonly rewarding stimuli (Hatzigiakoumis, 
Martinotti, Giannantonio, & Janiri, 2011).  Anh is relatively stable (Franken, Rassin, & 
Muris, 2007) but malleable (Farabaugh et al., 2015). It is closely related to depression but is a 
conceptually distinct construct (Leventhal, Chasson, Tapia, Miller, & Pettit, 2006). Although 
Anh was originally implicated in the etiology and maintenance of depressive disorders (e.g., 
Lewinsohn, 1974), it has since been found to be associated with other forms of 
psychopathology, such as social anxiety (e.g., Kashdan, 2004).  
Anhedonia and smoking cessation. Anh is related to poorer smoking cessation 
outcomes. To illustrate, among treatment-seeking smokers, greater Anh was associated with 
greater rates of relapse one, seven, and 14 days post-quit after accounting for the variance 
attributable to AS (Zvolensky et al., 2009). Among smokers who were enrolled in a smoking 
cessation program, greater baseline Anh was associated with greater rates of relapse eight 
(Cook et al., 2015; Leventhal, Ramsey, Brown, LaChance, & Kahler, 2008), 16, and 24 
weeks post-quit (Leventhal et al., 2008). Similarly, after accounting for the variance 
attributable to depressed mood, Anh predicted greater odds of relapse (Leventhal, Piper, 
Japuntich, Baker, & Cook, 2014) and faster latency to relapse (Cook, Spring, McChargue, & 
Doran, 2010) among smokers undergoing an aided quit attempt. Moreover, greater Anh was 
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associated with relapsing more quickly during a month-long self-quit attempt (Niaura et al., 
2001). Among non-treatment-seeking smokers, Anh was positively correlated with number of 
prior quit attempts and a higher proportion of past quit attempts ending in relapse within one 
day (Leventhal, Waters, Kahler, Ray, & Sussman, 2009). Taken together, Anh has been 
found to be associated with poorer smoking cessation outcomes in several studies, even after 
statistically controlling for other transdiagnostic reactive factors (i.e., AS) and depressive 
symptoms.  
Anhedonia and smoking-related risk factors. Greater Anh was associated with 
greater craving (Cook et al., 2015; Cook, Spring, McChargue, & Hedeker, 2004; Leventhal, 
2010) and nicotine withdrawal symptoms (Langdon et al., 2013; Leventhal et al., 2008; 
Zvolensky et al., 2009) in several studies. In addition, greater Anh was associated with 
greater behavioral choice melioration motives (e.g., "Very few things give me pleasure each 
day like cigarettes"; Leventhal et al., 2009; Mickens et al., 2011), suggesting that individuals 
with higher levels of Anh may smoke to experience pleasure and cope with their inability to 
experience pleasure from other commonly rewarding stimuli. Further, Anh was significantly 
positively correlated with severity of nicotine dependence in several investigations 
(Leventhal et al., 2014; McChargue & Werth Cook, 2007; Mickens et al., 2011; Roys, Weed, 
Carrigan, & MacKillop, 2016). Taken together, greater Anh is associated with several 
smoking-related processes (e.g., behavioral choice melioration motives, nicotine 
dependence), which may partially account for its relation to poorer smoking cessation 
outcomes.   
Aerobic Exercise 
Aerobic exercise and smoking. Aerobic exercise acutely reduced smoking craving in 
numerous experimental studies (for review see Roberts, Maddison, Simpson, Bullen, & 
Prapavessis, 2012). These results are important given that craving prospectively contributes 
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to relapse (for review see Serre, Fatseas, Swendsen, & Auriacombe, 2015). In light of these 
findings, a recent randomized controlled trial (RCT; Smits et al., 2016) tested the efficacy of 
vigorous-intensity exercise as an aid to smoking cessation and found that for individuals with 
high AS, follow-up abstinence rates were higher among individuals who participated in the 
smoking cessation/exercise condition compared to individuals who participated in the 
smoking cessation/wellness condition.  
Aerobic exercise and transdiagnostic factors. Aerobic exercise may impact 
smoking cessation outcomes through its effects on AS. Aerobic exercise reduced AS in 
several studies (Broman-Fulks, Berman, Rabian, & Webster, 2004; Broman-Fulks, Kelso, & 
Zawilinski, 2015; Broman-Fulks & Storey, 2008; LeBouthillier & Asmundson, 2015; Smits 
et al., 2008), even from a single session (Broman-Fulks et al., 2015; LeBouthillier & 
Asmundson, 2015). Yet, a single 20-30 minute bout of aerobic exercise did not increase 
perceived DT (Broman-Fulks et al., 2015; LeBouthillier & Asmundson, 2015) and no known 
studies have tested whether longer-term aerobic exercise impacts perceived DT. Further, no 
known studies have examined the effect of exercise on behavioral DT or Anh.  
Hatha Yoga 
Hatha yoga and smoking cessation. Aerobic exercise may serve as a useful aid for 
smoking cessation (e.g., Smits et al., 2016), yet some smokers may find aerobic exercise to 
be intolerable or may be unable to engage in aerobic exercise for medical reasons (as 
proposed by Elibero, Janse Van Rensburg, & Drobes, 2011). Yoga may serve as an 
alternative form of exercise to aid these individuals in their smoking cessation attempts. Yoga 
is a mind-body practice that originates in ancient Indian philosophy and consists of physical 
postures, breathing exercises, and meditation (National Center for Complementary and 
Integrative Health, 2016). Hatha yoga is the most common type of yoga practiced in the 
United States and emphasizes postures and breathing techniques to facilitate meditation 
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(Hofmann, Andreoli, Carpenter, & Curtiss, 2016; National Center for Complementary and 
Integrative Health, 2016). The utility of hatha yoga has been demonstrated for a number of 
mental and physical health problems (Hofmann et al., 2016; Raub, 2002; Uebelacker, 
Epstein-Lubow, et al., 2010) and shows promise as an aid to smoking cessation.  
Demonstrating hatha yoga’s potential utility as an aid to smoking cessation, one non-
randomized pilot study demonstrated that smoking abstinence was 29% following a group 
behavioral therapy for smoking cessation plus 30 minutes of hatha yoga (Burns, Mayer, 
Washington-Krauth, Walters, & Arouni, 2016). Another randomized study showed that, 
among adult women smokers who completed group-based CBT for smoking cessation plus a 
twice-weekly hatha yoga program or a wellness program, the hatha yoga condition was 
associated with greater seven-day point-prevalence abstinence (PPA) rates compared to the 
wellness condition (Bock et al., 2012). At six months post-treatment, abstinence rates among 
individuals in the hatha yoga group were higher (18.8%) than individuals in the control group 
(13%; OR = 1.54), though this effect was not statistically significant. This small effect could 
be due to participants failing to continue practicing hatha yoga post-treatment, but this was 
not explored in Bock and colleagues’ study. These results suggest that hatha yoga may be 
helpful for increasing cessation success in the short-term. Yet, it remains unknown whether 
hatha yoga could aid smoking reduction or cessation as a standalone intervention or among 
populations more at-risk for cessation failure, such as smokers with elevated 
anxiety/depression symptoms.  
Hatha yoga and smoking-related risk factors. Among 20 smokers who were not 
interested in quitting smoking, weekly hatha yoga was associated with in an increase in 
participants’ desire to quit smoking (McIver, O'Halloran, & McGartland, 2004). Another 
study examined the efficacy of a 32-session yoga intervention implemented within public 
school for reducing substance use risk factors among adolescents (Butzer, LoRusso, Shin, & 
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Khalsa, 2017). Adolescents in the yoga condition, as compared to the control condition 
(physical education as usual), were significantly less willing to try smoking cigarettes after 
the intervention. In contrast, no significant differences were found between groups in terms 
of smoking at follow-up. 
Hatha yoga acutely affects craving (Elibero et al., 2011). After one hour of nicotine 
abstinence, 76 daily smokers were randomized to one of two exercise conditions or a control 
condition. Participants in the exercise conditions engaged in 30 minutes of hatha yoga led by 
an instructional video or 30 minutes of moderate-intensity aerobic exercise (i.e., walking 
briskly on a treadmill). Control participants watched a 30-minute educational video about 
exercise. Participants in both exercise conditions, compared to participants in the control 
condition, reported a decrease in craving to smoke. Hatha yoga resulted in similar reductions 
in craving as aerobic exercise, suggesting that it may have as much potential as an aid to 
smoking cessation as aerobic exercise. These results demonstrate that hatha yoga reduces 
craving among smokers who are not attempting to change their smoking but it is unclear 
whether these results would generalize to smokers who are trying to reduce or quit smoking. 
Hatha yoga, anxiety, and depression. Hatha yoga has been shown to reduce 
symptoms of anxiety and depression (e.g., Hofmann et al., 2016; Uebelacker, Epstein-
Lubow, et al., 2010). Hatha yoga encourages individuals to use present-centered awareness, 
non-reaction, and non-judgmental acceptance despite experiencing psychological or physical 
discomfort (i.e., mindfulness; Medina et al., 2015). This present-focused and nonjudgmental 
component of hatha yoga effectively reduces anxiety and depression symptoms because it is 
incompatible with these symptoms because they are associated with orientation to the future 
(e.g., anxious apprehension, worry) and to the past (e.g., post-event procesing, rumination; 
Hofmann, Sawyer, Witt, & Oh, 2010; Kabat-Zinn, 2003).  
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Hatha yoga and transdiagnostic factors. It is possible that hatha yoga impacts 
smoking and anxiety/depression symptoms through Leventhal and Zvolensky’s (2015) 
putative transdiagnostic mechanisms (i.e., AS, DT, Anh). Hatha yoga requires individuals to 
focus their attention on interoceptive cues and their breathing while simultaneously engaging 
in and switching between difficult, and possibly uncomfortable physical positions (Hewitt, 
1990). Thus, practice of hatha yoga may help individuals habituate to distressing emotional 
or physical states. In line with this hypothesis, an eight-week hatha yoga intervention 
increased perceived DT among women high in emotional eating (Medina et al., 2015). Yet, 
considering that approximately two thirds of smokers lapsed and one third of smokers 
relapsed within one week of quitting (Zvolensky et al., 2009), it is important to test whether 
hatha yoga increases perceived DT more rapidly than eight weeks among smokers. 
Additionally, no known studies have tested the impact of hatha yoga on behavioral DT. 
Hatha yoga may impact AS through similar processes as those proposed to affect DT. 
For example, the physical activity involved in hatha yoga produces symptoms similar to 
those characteristic of anxiety, such as increased heart rate and respiration, which causes fear 
in individuals with higher AS (Raub, 2002; Uebelacker, Epstein-Lubow, et al., 2010). Thus, 
hatha yoga may expose individuals to fear-provoking anxiety-related symptoms, which could 
promote habituation of these sensations. Further, the mindfulness aspect of hatha yoga may 
promote a nonjudgmental, gentle, and curious stance towards and acceptance of anxiety-
related sensations. However, we know of no studies testing the impact of hatha yoga on AS. 
Further, although no known studies have tested the impact of hatha yoga on Anh specifically, 
hatha yoga (Uebelacker, Epstein-Lubow, et al., 2010) and other mindfulness-based 
interventions (Hofmann et al., 2010) reduce depressive symptoms. It may be that these 
interventions impact depressive symptoms in part through their effects on Anh. Hatha yoga 
may be positively reinforcing in and of itself and the mindfulness aspect of hatha yoga may 
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aid individuals in engaging in other positively reinforcing activities with a curious, 
nonjudgmental attitude, thereby decreasing Anh (per Uebelacker, Tremont, et al., 2010). 
Taken together, hatha yoga may impact AS, DT, and Anh and could serve as an intervention 
strategy for a heterogeneous population of smokers.   
Study Aims and Hypotheses 
The current study aimed to further understanding of the utility of hatha yoga in 
smoking cessation in several ways. First, we aimed to extend prior work that demonstrated 
acute reductions in craving from one 30-minute session of hatha yoga among nicotine-
deprived smokers who were not attempting to reduce or quit smoking (Elibero et al., 2011) 
by testing whether one 30-minute session of hatha yoga resulted in less craving than a 30-
minute wellness control condition among smokers motivated to quit or reduce smoking who 
completed the intervention on their intervention day (i.e., the day on which they planned to 
begin reducing or quit smoking). We hypothesized that the hatha yoga condition would be 
associated with less craving compared to the control condition immediately following the 
intervention. Second, we aimed to test the impact of one session of hatha yoga on seven-day 
follow-up smoking outcomes. This is the first known study to test the effect of one session of 
hatha yoga on follow-up smoking. Considering that 75% of smokers who underwent a one-
session relaxation intervention smoked during the two weeks post-intervention (Dickson-
Spillmann et al., 2013), we anticipated that the majority of participants in the current study 
would smoke during the week following their intervention day. However, we hypothesized 
that participants in the hatha yoga condition would report smoking fewer cigarettes per day 
(CPD) at follow-up compared to participants in the control condition.  
Third, we tested whether anxiety/depression symptoms impacted the utility of hatha 
yoga for reducing craving and smoking. Specifically, we hypothesized that 
anxiety/depression symptoms would moderate the relationships between condition and post-
 17 
intervention craving and follow-up CPD such that participants in the control condition who 
endorse greater anxiety/depression symptoms would report greater post-intervention craving 
and greater follow-up CPD compared to participants in both conditions who endorse less 
anxiety/depression symptoms and participants in the hatha yoga condition who endorse 
greater anxiety/depression symptoms. 
Fourth, in light of data suggesting that long-term practice of hatha yoga increases 
perceived DT (Medina et al., 2015), and that other forms of exercise (e.g., aerobic exercise) 
decrease AS (e.g., Broman-Fulks et al., 2015), we aimed to extend prior work by testing the 
acute effect of one session of hatha yoga on AS, DT, and Anh. We hypothesized that on 
intervention day, one session of hatha yoga would be associated with less post-intervention 
AS and Anh and greater post-intervention DT compared to the control condition. Fifth, we 
tested whether one session of hatha yoga would be associated with less AS and Anh and 
greater DT than the control condition at follow-up. This is the first known study to examine 
the impact of hatha yoga on AS, behavioral DT, and Anh and the first known study to test the 
short-term impact of hatha yoga on perceived DT.  
Sixth, we aimed to test whether anxiety/depression symptoms impacted the utility of 
hatha yoga for changing AS, DT, and Anh, such that anxiety/depression symptoms would 
moderate the relationship between condition and post-intervention and follow-up AS, DT, 
and Anh. We hypothesized that participants in the control condition who endorse greater 
anxiety/depression symptoms at baseline would report greater post-intervention and follow-
up AS and Anh and less post-intervention and follow-up DT compared to participants in both 
conditions who endorse less anxiety/depression symptoms and participants in the hatha yoga 
condition who endorse greater anxiety/depression symptoms.  
The current study also had several secondary aims and hypotheses that represent 
novel contributions to the literature. We tested whether continued hatha yoga practice aided 
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in reducing smoking. Specifically, we gave participants in the hatha yoga condition the hatha 
yoga video and participants in the control condition wellness-related educational materials. 
We encouraged participants in both conditions to access their materials daily during the week 
following their intervention day. We hypothesized that number of minutes participants 
accessed their materials would moderate the relationship between condition and follow-up 
CPD, such that participants in the hatha yoga condition who reported accessing their 
materials more would report fewer follow-up CPD. Further, we tested whether number of 
minutes participants accessed their materials moderated the relationship between condition 
and changes in AS, DT, and Anh such that participants in the hatha yoga condition who 
report accessing their materials more would evidence less AS and Anh and greater DT at 
follow-up. 
Further, we examined the role of AS, DT, and Anh in the relationship between 
condition and smoking-related outcomes. We hypothesized that AS, DT, and Anh would 
mediate the relationship between condition and intervention day post-intervention craving. 
We also hypothesized that AS, DT, and Anh would mediate the relationship between 
condition and follow-up CPD. Lastly, we examined the impact of condition on seven-day 
PPA rates. It was hypothesized that the hatha yoga condition would be associated with 





Participants were current smokers who endorsed a desire to reduce or quit smoking. 
In addition to recruiting smokers who desired to quit smoking, we also recruited smokers 
who wanted to reduce their smoking considering that individuals who reduce their smoking 
are more likely to successfully quit smoking eventually and reductions in smoking are 
associated with positive health-related consequences (for review see Begh, Lindson-Hawley, 
& Aveyard, 2015). We recruited participants from the community (e.g., via flyers, through 
online advertisements on Craigslist and the university’s website) and through the university’s 
psychology participant pool. We used a subset of advertisements in an attempt to oversample 
for individuals with elevated anxiety/depression symptoms (e.g., flyer title: “Feeling stressed 
or sad? Want to cut down or quit smoking?”). This strategy was successfully used to recruit 
participants with elevated anxiety/depression symptoms in prior research (e.g., Afram & 
Kashdan, 2015).  
Informed by other smoking studies (Bowen & Marlatt, 2009; Elibero et al., 2011; 
Langdon, Farris, Hogan, et al., 2016; Olvera et al., 2015; Robles et al., 2017), eligibility 
criteria included: (1) being 18-65 years old, (2) average smoking rate of at least five CPD for 
at least the past year per the Smoking History Questionnaire (Brown et al., 2002), and (3) 
willingness to schedule and attend a laboratory appointment on the day the participant 
planned to begin reducing smoking or quit smoking. Exclusion criteria included: (1) self-
reported pregnancy, (2) using NRT and/or undergoing smoking cessation counseling at 
baseline, (3) having practiced yoga once per week or more in the past year, and (4) being 
unable to safely engage in exercise per the Physical Activity Readiness Questionnaire (unless 
the participant received signed physician permission to participate in the study [n = 0]; 
Chisholm, Collis, Kulak, Davenport, & Gruber, 1975). We used two additional exclusion 
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criteria early in study recruitment. “Having decreased the number of daily cigarettes smoked 
by more than half in the past six months” was removed upon consultation with an expert in 
smoking cessation research. “If currently receiving treatment for anxiety and/or depression, 
be willing to remain on stable dose throughout duration of the study” was removed given that 
the study duration was only one week.  
See Figure 1 for a CONSORT flow diagram. Of the 867 individuals who completed 
the online screening questionnaire between February 2017 and May 2018, 569 were 
ineligible due to: being unable to safely exercise (n = 162),1 smoking less than five cigarettes 
per day (n = 123),2 indicating unwillingness to attend an appointment (n = 100), having 
practiced yoga once per week or more during the past year (n = 84), currently using NRT or 
smoking cessation counseling (n = 37), having recently decreased smoking by at least half (n 
= 27), having regularly smoked for less than one year (n = 12), being pregnant (n = 8), 
endorsing low motivation to change smoking (n = 8), being under the age of 18 (n = 7), and 
planning to change psychiatric treatment during study period (n = 1).  
Of the 298 participants who were eligible, 149 scheduled an intervention day 
appointment. Of the 58 participants who presented for their intervention day appointment, 
two were ineligible to participate due to smoking less than five cigarettes per day. Of the 56 
participants enrolled in the study, 52 completed follow-up. One participant in the wellness 
condition was classified as a random responder at baseline (as described below), thus, that 
participant’s data were not analyzed. The final baseline sample consisted of 55 participants 
(hatha yoga n = 25, wellness condition n = 30) and the follow-up sample consisted of 51 
participants (hatha yoga n = 25, wellness condition n = 26). The majority of participants 
(85.5%) were community-recruited. The final sample was primarily male and non-Hispanic 
White (Table 1), aged 18 to 60 years old. The majority of the sample reported having 




Figure 1. Participant flow chart following Consolidated Standards of Reporting Trials 
guidelines    
 22 
Table 1. Demographic and Baseline Characteristics of Sample by Condition 
 Total (N = 55) Yoga (n = 25) Control (n = 30) F or 
2 
p d or 
Cramer’s V 
Age 28.16 (10.40) 28.44 (10.88) 27.93 (10.17) 0.03 .859 0.05 
Gender (% male) 61.81 68.00 56.67 0.74 .389 0.12 
Sexual orientation (% heterosexual) 85.45 88.00 83.33 0.24 .625 0.07 
     Lesbian (%) 1.82 0.00 3.33    
     Gay (%) 1.82 4.00 0.00    
     Bisexual (%) 10.91 8.00 13.33    
Race/Ethnicity (% White/Non-Hispanic) 71.00 72.00 70.00 0.03 .871 0.02 
     White/Hispanic (%) 7.27 8.00 6.67    
     African American (%) 9.10 8.00 10.00    
     Asian (%) 7.27 8.00 6.67    
     Multiracial (%) 1.82 0.00 3.33    
     Other (%) 3.64 4.00 3.33    
Employment status (% employed) 67.27 64.00 70.00 0.22 .637 0.06 
Family income 85,612 (80, 707) 61,896 (72,226) 104,585 (83,241) 3.94 .053 0.55 
Student status (% student) 65.45 56.00 73.33 1.81 .178 0.18 
Level of education (% > high school) 87.76 83.36 88.89 0.07 .789 0.04 
Marital status (% single) 67.27 72.00 63.33 0.47 .495 0.09 
Religion (% Atheist/Agnostic) 27.27 24.00 30.00 0.25 .619 0.07 
Treatment status (% in treatment) 21.82 20.00 23.33 0.09 .766 0.04 
DASS-21 total 29.53 (19.21) 28.24 (19.01) 30.60 (19.63) 0.20 .654 0.12 
DASS-21 depression 8.29 (8.35) 8.16 (9.64) 8.40 (7.27) 0.01 .917 0.03 
DASS-21 anxiety 8.25 (6.88) 8.40 (7.30) 8.13 (6.62) 0.02 .888 0.04 
DASS-21 stress 11.16 (7.34) 10.08 (6.77) 12.07 (7.78) 0.99 .322 0.27 
Anxiety sensitivity 22.35 (13.38) 20.20 (12.75) 24.13 (13.84) 1.18 .282 0.30 
Perceived distress tolerance 3.17 (0.96) 3.34 (1.01) 3.03 (0.91) 1.45 .235 0.32 
       
(Table 1 continued)       
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Total (N = 55) Yoga (n = 25) Control (n = 30) F or 
2 
p d or 
Cramer’s V 
Breath-holding 47.25 (20.81) 45.44 (18.63) 48.76 (22.68) 0.34 .561 0.16 
PASAT 199.85 (129.70) 180.18 (134.12) 216.23 (125.80) 1.06 .309 0.28 
Anhedonia 18.93 (4.16) 18.36 (3.87) 19.40 (4.39) 0.85 .361 0.24 
Past-week cigarettes per day 9.02 (5.22) 8.35 (5.21) 9.60 (5.26) 0.77 .385 0.24 
Hours since last cigarette 10.37 (13.19) 12.42 (16.36) 8.65 (9.79) 1.13 .294 0.28 
CO in breath 8.69 (7.69) 7.40 (5.45) 9.77 (9.11) 1.30 .260 0.32 
FTND 2.98 (2.01) 2.52 (1.98) 3.37 (1.99) 2.48 .122 0.43 
Total years smoking 10.53 (9.70) 10.48 (10.15) 10.57 (9.49) 0.00 .974 0.01 
Number of quit attempts 3.20 (2.59) 2.92 (2.45) 3.43 (2.73) 0.53 .470 0.20 
Electronic nicotine use (%) 14.55 12.00 16.67 0.24 .625 0.07 
Past-week cannabis use (%) 34.55 40.00 30.00 0.60 .437 0.11 
Past-week alcohol use (%) 72.73 64.00 80.00 1.76 .185 0.18 
Note. Means and standard deviations are presented unless noted otherwise. DASS-21 = Depression Anxiety and Stress Scales (Lovibond & 
Lovibond, 1995); treatment status = whether participant is being treated for anxiety and/or depression; FTND = Fagerström Test for Nicotine 
Dependence (Heatherton et al., 1991). 
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Participants randomized to hatha yoga (100%) were not significantly more likely to 
complete follow-up than participants randomized to the control condition (86.67%), 2 (1, N 
= 55) = 3.60, p = .058, φ = 0.26. Completers did not significantly differ from non-completers 
in terms of gender (35.29% vs. 75% female), 2 (1, N = 55) = 2.48, p = .115, φ = 0.21, age (M 
= 28.02, SD = 10.55 vs. M = 30.00, SD = 9.42), F(1, 53) = 0.13, p = .718, d = 0.20, or race 
and ethnicity (72.55% vs. 50.00% non-Hispanic White), 2 (1, N = 55) = 0.91, p = .339, φ = 
0.13. Completers also did not differ from non-completers on baseline CPD (M = 9.39, SD = 
5.93) vs. M = 8.86, SD = 1.94), F(1, 53) = 0.03, p = .860, d = 0.12, or anxiety/depression (M 
= 28.24, SD = 18.02 vs. M = 46.00, SD = 28.98), F(1, 53) = 3.31, p = .075, d = 0.68.    
Measures 
 Screening. Participants were asked if they were engaging in NRT or smoking 
cessation counseling and if they were women, if they were pregnant. Participants who 
answered “yes” to either of these questions were excluded from the study. Items from the 
Smoking History Questionnaire (Brown et al., 2002) assessed the total number of years 
participants have been daily smokers and the average numbers of cigarettes smoked per day 
since becoming a regular smoker and during the past week. The Physical Activity Readiness 
Questionnaire (Chisholm et al., 1975) is a self-report questionnaire consisting of seven items 
that assessed physical symptoms that could limit participants’ ability to safely engage in 
exercise.  
Descriptive information. Biochemical verification of smoking status was obtained at 
baseline using CO (carbon monoxide) analysis of breath samples. Additionally, we assessed 
number of hours since participants last smoked a cigarette at baseline. Participants completed 
the 6-item Fagerström Test for Nicotine Dependence (Heatherton et al., 1991) to provide 
descriptive information about their level of nicotine dependence at baseline and follow-up. 
The Fagerström Test for Nicotine Dependence has demonstrated high test-retest reliability 
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and concurrent validity (Heatherton et al., 1991; Pomerleau, Carton, Lutzke, Flessland, & 
Pomerleau, 1994), though has generally demonstrated low internal consistency reliability 
(e.g., Pomerleau et al., 1994). Similar to previous research (e.g., Pomerleau et al., 1994), the 
Fagerström Test for Nicotine Dependence evidenced poor internal consistency reliability in 
the current sample (baseline α = .53). Additional questions from the Smoking History 
Questionnaire (e.g., number of past “serious” quit attempts) were asked to provide 
descriptive information about the sample. At follow-up, participants indicated whether they 
used any methods to help them reduce or quit smoking other than the materials we gave to 
them (e.g., NRT, counseling). Participants also indicated whether they completed any yoga 
other than the yoga from the study and whether they read any wellness materials other than 
the wellness materials from the study.  
Dependent variables. Participants completed the self-report Timeline Followback 
(TLFB; Sobell & Sobell, 1992) to provide information about cigarettes smoked per day 
during the seven days prior to baseline and seven days prior to follow-up. We also assessed 
past-week cannabis and alcohol use with the self-report TLFB to assess whether use of these 
substances changed from baseline to follow-up. Self-report versions of the TLFB for these 
substances have demonstrated high reliability and validity (Harris et al., 2009; Pedersen, 
Grow, Duncan, Neighbors, & Larimer, 2012; Ramo, Hall, & Prochaska, 2011). Additionally, 
computer-administered versions of the TLFB have shown good test-retest reliability (Sobell, 
Brown, Leo, & Sobell, 1996). Prior work evaluating smoking outcomes following brief 
interventions for smoking have used self-report measures of smoking (e.g., Bowen & Marlatt, 
2009). In the current study, past-week CPD per the TLFB was significantly correlated with 
expired CO in breath samples at baseline, r(53) = .51, p < .001, demonstrating convergent 
validity.  
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We assessed craving (i.e., desire to smoke) by asking participants to rate the 
statement, “I have a desire for a cigarette right now”, on a 7-point Likert-type scale with 1 
indicating strongly disagree, 4 indicating neither agree nor disagree, and 7 indicating 
strongly agree (Tiffany & Drobes, 1991). Utilizing a single-item measure of craving is 
appropriate in situations in which craving is expected to be high (e.g., during nicotine 
abstinence) and is assessed repeatedly in a short timeframe as using a single item may reduce 
reactivity associated with self-report assessment of craving (Sayette et al., 2000). We 
assessed craving on intervention day immediately prior to randomization and immediately 
post-intervention and at follow-up.  
We assessed AS using the Anxiety Sensitivity Index-3 (ASI-3; Taylor et al., 2007), an 
18-item self-report measure. Participants rated items (e.g., “It scares me when my heart beats 
rapidly”) on a 0 (very little) to 4 (very much) Likert-type scale. Higher scores indicate higher 
levels of AS. The ASI-3 has evidenced good internal consistency reliability, convergent and 
discriminant validity, and test-retest reliability among smokers (Farris, DiBello, et al., 2015). 
The ASI-3 evidenced excellent internal consistency reliability in the current sample (baseline 
α = .90). Participants completed the ASI-3 at baseline on intervention day, post-intervention 
on intervention day, and at follow-up. 
We assessed perceived DT using the Distress Tolerance Scale (DTS; Simons & 
Gaher, 2005), a self-report questionnaire consisting of 15 items (e.g., “I can’t handle feeling 
distressed or upset”) that participants rated on a 1 (strongly agree) to 5 (strongly disagree) 
Likert-type scale. A total score was computed by averaging responses on all DTS items. 
Lower scores on the DTS represent lower perceived ability to tolerate negative emotional 
states. The DTS has demonstrated good internal consistency reliability, convergent and 
discriminant validity, criterion-related validity, and test-retest reliability (Simons & Gaher, 
2005). Additionally, the DTS has demonstrated excellent internal consistency reliability 
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among smokers (Kraemer et al., 2013). The DTS also demonstrated excellent internal 
consistency reliability in the current sample (baselineα = .93). Participants completed the 
DTS at baseline on intervention day, post-intervention on intervention day, and at follow-up. 
We assessed behavioral DT in two ways: using a BH assessment (Hajek et al., 1987) 
and using a computerized PASAT (Lejuez, Kahler, & Brown, 2003). We assessed BH at 
baseline on intervention day, post-intervention on intervention day, and at follow-up and 
participants completed the PASAT at baseline and post-intervention on intervention day. We 
did not administer the PASAT at follow-up because participants cannot complete it remotely. 
Although the BH assessment has been the most commonly used measure of behavioral DT in 
the smoking literature (Leventhal & Zvolensky, 2015), the PASAT was used as a second 
measure of behavioral DT because hatha yoga could impact participants’ BH abilities without 
actually impacting their ability to tolerate physical distress. During the BH assessment, we 
asked participants to hold their breath for as long as possible. Each participant completed two 
trials per time period (i.e., pre-intervention, post-intervention, follow-up) and the two trials 
were averaged to create a total BH score. Shorter BH duration indicates lower behavioral DT. 
Participants completed the BH assessment remotely using instructions on Qualtrics.com at 
follow-up.  
The PASAT required participants to add a newly presented numeric digit to a numeric 
digit previously presented. After inputting the sum on the keyboard, participants were 
required to ignore that sum and add the numeric digit presented next to the numeric digit 
presently immediately prior. Digits were presented more quickly over the course of the task, 
which consisted of three trials. Additionally, participants heard an unpleasant noise when 
they gave incorrect responses. Participants were allowed to quit the task at any time during 
the final trial. The amount of time until participants quit the task during the final trial was 
used as the measure of DT. Numerous studies of smokers have utilized these behavioral 
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measures of DT (e.g., Brown et al., 2002; Cameron et al., 2013; Daughters et al., 2005; Hajek 
et al., 1987; MacPherson, Stipelman, Duplinsky, Brown, & Lejuez, 2008).  
We assessed Anh using the 14-item Snaith-Hamilton Pleasure Scale (SHAPS; Snaith 
et al., 1995). Participants rated the degree of pleasure they believed they would experience if 
they engaged in several hypothetical activities (e.g., “I would find pleasure in my hobbies 
and pastimes”). Each item has four response options: definitely agree (0), agree (1), disagree 
(2), and definitely disagree (3). Higher total scores indicate greater Anh. The SHAPS has 
demonstrated good internal consistency reliability among smokers (Leventhal et al., 2009), 
excellent construct, convergent, and divergent validity (Leventhal et al., 2006), and excellent 
test-retest reliability (Franken et al., 2007).  In the current sample, the SHAPS demonstrated 
good internal consistency reliability (baselineα = .81). Participants completed the SHAPS at 
baseline on intervention day, post-intervention on intervention day, and at follow-up. 
Putative moderators. We assessed anxiety/depression with the DASS-21 (Lovibond 
& Lovibond, 1995) at baseline and follow-up. The DASS-21 consists of three subscales each 
comprising seven items assessing past-week anxiety, depression, and stress. The total score 
was used as a measure of anxiety/depression. Respondents rated items (e.g., “I felt I was 
close to panic”, “I felt down-hearted and blue”) on a 0 (did not apply to me at all) to 3 
(applied to me very much, or most of the time) Likert-type scale. The total score is multiplied 
by two. The DASS-21 has evidenced good internal consistency reliability, convergent and 
discriminant validity, and criterion validity (Antony, Bieling, Cox, Enns, & Swinson, 1998; 
Henry & Crawford, 2005). In the current sample, the DASS-21 total score evidenced good 
internal consistency reliability (baseline α = .89). At follow-up, participants indicated for 
how many minutes they accessed the materials given to them each day during the follow-up 
period using a calendar adapted from the TLFB (Sobell & Sobell, 1992). We summed 
minutes per day to create a total number of minutes materials were used.  
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We used the Infrequency Scale (Chapman & Chapman, 1983) at baseline and follow-
up to identify random responders who may have provided random or grossly invalid 
responses. Four questions from the IS (e.g., “I find that I often walk with a limp, which is the 
result of a skydiving accident”) were included. As in prior studies (Buckner, Ecker, & Dean, 
2016), individuals who endorsed three or more infrequency items were classified as random 
responders (n = 1 at baseline, n = 0 at follow-up).  
Conditions 
 Hatha yoga condition. Hatha yoga in the current study was conceptualized by 
previous research conducted in the United States (Bock et al., 2012; Elibero et al., 2011) and 
by the National Center for Complementary and Integrative Health (National Center for 
Complementary and Integrative Health, 2016) but may not be fully reflective of traditional 
hatha yoga practice. Participants in the hatha yoga condition were in a room with a yoga mat 
and were asked to follow a 30-minute instructional hatha yoga video. A certified yoga 
instructor developed the video specifically for the current study. The video starts with a 
breathing exercise, followed by a warm-up, and a basic hatha yoga routine that can be 
completed easily by a relatively healthy individual. The video ends with meditation. To 
ensure adherence with the video instructions, a research assistant observed participants in an 
adjacent room using video recording equipment. We instructed research assistants that if they 
observed that the participant was not adhering to the instructions, the research assistant was 
to encourage the participant to follow the instructions (however, all participants were 
adherent). At the end of the session, we gave participants a copy of the video and emailed 
them a link of the video. We encouraged participants to practice hatha yoga once per day 
during the next seven days. Participants were not explicitly told that there is a relationship 
between hatha yoga and smoking cessation.  
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Wellness control condition. Participants in the control condition read educational 
materials about wellness for 30 minutes per prior smoking cessation trials (Smits et al., 
2012). Wellness has been successfully used as a control condition in other exercise 
intervention studies (Chasan-Taber et al., 2009; Marcus et al., 1995; Pekmezi et al., 2009; 
Smits et al., 2016). We provided participants a description of the program and asked them to 
read about wellness-related topics such as cancer prevention and stress management for 30 
minutes. We gave participants a printout copy of the wellness materials and emailed them a 
copy of the wellness materials. We encouraged them to read the materials once per day 
during the next seven days. Participants were not told that there is a relationship between 
overall wellness and smoking cessation.  
Procedures 
 Participants completed an online screening survey via Qualtrics.com, a secure, online 
data-collection website. We provided ineligible participants smoking cessation resources, 
including referrals for local smoking cessation clinics and a link to a website detailing 
smoking cessation strategies (Centers for Disease Control and Prevention, 2017b). We 
invited eligible participants to choose an appointment date on which they would begin to 
reduce smoking or quit smoking within the following four weeks. In addition to asking 
participants to refrain from smoking cigarettes on their intervention day, we asked them to 
refrain from smoking other substances that day (because smoking other substances increases 
expired CO levels; e.g., Newmeyer, Swortwood, Abulseoud, & Huestis, 2017).  
During the appointment, participants provided written informed consent prior to data 
collection. We obtained a certificate of confidentiality from the National Institutes of Health 
to ensure confidentiality and security of data.  Next, we obtained biochemical verification of 
smoking status using CO analysis of breath samples and we asked participants when they last 
smoked a cigarette. Participants who were not abstinent from smoking that day (n = 34) 
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remained eligible to participate. Participants then completed baseline measures. We gave all 
participants a handout describing strategies that can be used to quit smoking (Centers for 
Disease Control and Prevention, 2017b). Next, while participants read the handout, we used 
urn randomization (i.e., randomization that is systematically biased in favor of balancing; 
Stout, Wirtz, Carbonari, & Del Boca, 1994) to randomize them to ensure equal distribution of 
relevant variables (i.e., gender, race and ethnicity, baseline CPD, anxiety, depression, 
currently receiving treatment for anxiety and/or depression) between conditions. Participants 
then completed 30 minutes of hatha yoga per an instructional video or read wellness-related 
educational materials for 30 minutes. Next, participants completed post-intervention 
measures. In addition to their intervention materials (described above), we provided all 
participants the link to a website describing the strategies that can be used to quit smoking 
and we encouraged them to review the website (Centers for Disease Control and Prevention, 
2017b). 
We informed participants that they would be sent an email seven days after their 
appointment to complete follow-up measures via Qualtrics.com. Upon completion of the 
study, we compensated LSU psychology undergraduate students with research credit points. 
We compensated community-recruited participants $25 for attending the laboratory 
appointment and entered them into a drawing to win money (i.e., one $100, two $50 prizes) 
for completing the follow-up assessment. We also provided participants with referrals for 
mental health and smoking cessation treatment upon completion of the study. Additionally, 
after participants completed the follow-up assessment, we provided them the materials from 
the other condition (i.e., hatha yoga video or wellness materials) via email.  
Data Analytic Strategy 
First, to ensure that conditions did not differ on relevant variables (i.e., gender, race 
and ethnicity, time since last cigarette, baseline CPD, anxiety, depression, currently receiving 
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treatment for anxiety and/or depression), we conducted a one-way analysis of variance 
(ANOVA) for each continuous dependent variable and a chi-square analysis was conducted 
for each categorical dependent variable. To test the impact of condition on post-intervention 
craving and follow-up smoking outcomes, we conducted an ANOVA for each outcome 
variable. To test the moderating role of anxiety/depression symptoms on the relationships 
between condition and post-intervention craving and follow-up smoking, we conducted a 
series of hierarchical linear regressions. Regression with dichotomous independent variables 
is robust against differences in sample size between conditions (West, Aiken, & Krull, 1996). 
We conducted separate hierarchical linear regressions for each outcome variable. Predictor 
variables were: Step 1: baseline craving or baseline CPD, Step 2: main effects of condition 
(wellness control condition = 0, hatha yoga condition = 1) and anxiety/depression symptoms, 
and Step 3: the Condition x Anxiety/Depression interaction. This strategy ensured that effects 
at Step 3 were not attributable to the variance shared with variables in Steps 1 and 2 (Cohen 
& Cohen, 1983). For all regression analyses, we centered continuous independent variables 
(Holmbeck, 2002) and squared part (i.e., semipartial) correlations to estimate effect sizes 
(Cohen & Cohen, 1983). Further, we examined the forms of significant interactions by 
graphing regression lines of the association between condition and the outcome variable (e.g., 
follow-up CPD) for individuals with high (one SD above the sample mean) and low (one SD 
below the sample mean) levels of the moderator (e.g., anxiety/depression) and probed 
significant interactions by testing whether simple slopes of the regression lines were 
significantly different from zero (Aiken & West, 1991; Holmbeck, 2002).  
To test the impact of condition on post-intervention and follow-up AS, DT, and Anh, 
we conducted an ANOVA for each outcome variable. To test the moderating role of 
anxiety/depression in the relationship between condition and post-intervention and follow-up 
AS, DT, and Anh, we conducted a series of hierarchical linear regressions. We conducted 
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separate regressions for each dependent variable after controlling for baseline levels of each 
variable. Predictor variables were: Step 1: baseline AS, DT, or Anh, Step 2: main effects of 
condition and anxiety/depression, and Step 3: the Condition x Anxiety/Depression 
interaction.  
To test whether number of minutes participants accessed their materials during the 
follow-up period moderated the relationship between condition and each continuous outcome 
after controlling for baseline levels of each outcome variable, we conducted another series of 
hierarchical linear regression analyses. We conducted separate hierarchical linear regressions 
for each outcome: follow-up CPD, follow-up AS, follow-up DT, and follow-up Anh. 
Predictor variables were: Step 1: baseline score for each outcome variable, Step 2: main 
effects of condition and number of minutes participants accessed their materials, and Step 3: 
the Condition x Number of Minutes Participants Accessed Their Materials interaction.   
PROCESS (a macro used within IBM SPSS) was used was used to test our mediation 
hypotheses (Hayes, 2013). PROCESS uses an ordinary least squares regression-based path 
analytical framework to test for direct and indirect effects (Hayes, 2013). The program 
estimated bias-corrected 95% confidence intervals using bootstrapping analyses with 10,000 
resamples (Hayes, 2009). First, we examined whether condition was associated with putative 
mediators, including post-intervention AS, post-intervention DT, post-intervention Anh, 
follow-up AS, follow-up DT, and follow-up Anh. We conducted mediation analyses for each 
dependent variable (i.e., post-intervention craving or follow-up CPD) using only proposed 
mediators that were significantly associated with condition. We estimated effect sizes of 
indirect effects using partially standardized effects given that the independent variable (i.e., 
condition) is dichotomous (Hayes, 2013). Lastly, we conducted a hierarchical logistic 
regression to test the impact of condition on seven-day PPA. Predictor variables were: Step 1: 
baseline CPD, Step 2: condition. We used an odds ratio (Field, 2009) to determine effect size.  
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A Priori Power Analysis 
 Previous studies investigating the effects of exercise on smoking craving have found 
medium to large effects (for review see Roberts et al., 2012). Although no studies have 
examined the effects of hatha yoga alone compared to a control condition on follow-up 
smoking, a study investigating the effects of a brief mindfulness-based instruction set (i.e., 
urge surfing) compared to a control condition on follow-up CPD found a medium to large 
effect (d = 0.64; Bowen & Marlatt, 2009). Thus, we used G*Power (Faul, Erdfelder, Lang, & 
Buchner, 2007) to estimate the sample size needed to detect a medium effect (f2 = 0.25) with 
power of 0.80 and an alpha level of .05 for a linear multiple regression analysis using four 
predictor variables (i.e., baseline CPD, condition, anxiety/depression, and Condition x 
Anxiety/Depression interaction). According to G*Power (Faul et al., 2007), 48 participants 
should provide sufficient power to test our primary hypotheses, as this sample size is 
sufficient to test our primary hypothesis requiring the largest sample size (i.e., moderation 
hypothesis). Thus, our baseline and follow-up sample sizes are sufficient to test study 





 First, we inspected data for outliers (greater than three standard deviations from the 
mean). We observed outliers for the following variables: baseline CPD (n = 1), post-
intervention AS (n = 1), post-intervention Anh (n = 1), post-intervention BH (n = 1), follow-
up anxiety/depression (n = 1), follow-up BH (n = 1), number of minutes participants accessed 
their materials at follow-up (n = 1), and follow-up CPD (n = 1).  We removed outliers for 
each of these measures prior to conducting study analyses utilizing the measure. Table 2 
presents means, standard deviations, skew, and kurtosis values for independent variables, 
covariates, and dependent variables. Data were not significantly skewed (> 3) or kurtotic (> 
10; Field, 2009).   
Table 2. Means, Standard Deviations, Skew, and Kurtosis of Study Variables  
 M SD Skew Kurtosis 
Baseline DASS-21  29.53 19.21 0.70 0.28 
Baseline CPD 9.02 5.22 0.85 0.10 
Baseline AS 22.35 13.38 0.70 -0.40 
Baseline DT 3.67 0.96 -0.07 -0.47 
Baseline BH 47.25 20.81 0.67 0.51 
Baseline PASAT 199.85 129.70 -0.65 -1.51 
Baseline Anh 18.93 4.16 0.58 -0.82 
Baseline craving 5.04 1.63 -0.72 -0.28 
Post-intervention AS 16.65 12.52 0.74 -0.81 
Post-intervention DT 3.87 1.01 -0.27 -0.44 
Post-intervention BH 44.68 20.63 0.94 1.35 
Post-intervention PASAT 171.39 141.13 -0.23 -1.96 
Post-intervention Anh 18.19 3.74 0.68 -0.46 
Post-intervention craving 4.18 2.07 -0.15 -1.16 
Follow-up DASS-21  23.00 18.12 1.20 1.33 
Follow-up AS 14.55 12.14 1.12 0.45 
Follow-up DT 3.53 0.92 -0.13 -0.54 
Follow-up BH 37.42 23.41 1.30 3.40 
Follow-up Anh 19.39 5.17 0.70 -0.71 
Minutes accessed materials 102.90 81.86 0.42 -0.88 
Follow-up craving 3.47 1.90 0.32 -0.97 
Follow-up CPD 4.32 3.88 1.27 1.88 
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At baseline, 60% of participants endorsed depression within the normal range, 14.5% 
endorsed depression within the mild range, 14.6% endorsed depression within the moderate 
range, 9.1% endorsed depression within the severe range, and 1.8% endorsed depression 
within the extremely severe range (Lovibond & Lovibond, 1995). Regarding anxiety at 
baseline, 50.9% of participants endorsed anxiety within the normal range, 9.1% endorsed 
anxiety within the mild range, 23.6% endorsed anxiety within the moderate range, 7.3% 
endorsed anxiety within the severe range, and 9.1% endorsed anxiety within the extremely 
severe range (Lovibond & Lovibond, 1995). Participants in the current study smoked fewer 
CPD and had lower levels of nicotine dependence at baseline than participants in prior 
studies testing the utility of exercise for smoking cessation (Bock et al., 2012; Smits et al., 
2016), but smoked more CPD and had greater nicotine dependence than participants in a 
study testing the efficacy of a brief mindfulness-based intervention (i.e., urge surfing) for 
smoking reduction (Bowen & Marlatt, 2009). Although all participants endorsed being 
regular, daily smokers for at least the past year at screening, only 83.6% of participants 
endorsed past-week daily smoking at baseline.  
 Conditions did not significantly differ on demographic variables, anxiety, depression, 
stress, or smoking variables at baseline (Table 1). At baseline, anxiety/depression symptoms 
were significantly positively associated with AS, Anh, and craving, were significantly 
negatively associated with perceived DT, and were not significantly correlated with CPD 
(Table 3). Additionally, nicotine dependence was significantly positively associated with 
CPD and craving at baseline (Table 3). Further, at baseline, BH and PASAT were not 
significantly correlated with perceived DT and these two behavioral measures of DT were 




Table 3. Correlations among Baseline Variables 
 1 2 3 4 5  6  7  8 
1. Anxiety/depression         
2. CPD .22        
3. FTND .16 .42**       
4. AS .48** .15 .08      
5. DT -.44** .09 -.01 -.64**     
6. BH -.17 .12 -.24 -.17 .19    
7. PASAT -.06 -.08 .00 .12 -.10 .06   
8. Anh .42** .08 .22 .26 -.20 -.18 -.16  
9. Craving .34* .10 .52** .18 -.12 -.11 .09 .21 
Note. *p < 0.05, **p < .01.   
 
Participants in the hatha yoga condition reported using their study materials for 
significantly more minutes and on significantly more days than participants in the wellness 
control condition during the follow-up period (Table 4). At follow-up, number of minutes 
participants accessed their materials was significantly negatively correlated with craving, 
r(48) = -.32, p = .023, but not CPD, r(47) = -.09, p = .532. Consistent with their intentions to 
reduce or quit smoking, participants (regardless of condition) smoked significantly less CPD 
at follow-up (M = 4.63, SD = 4.43) than at baseline (M = 9.39, SD = 5.93), t (50) = 6.75, p < 
.001, d = 0.91. Regarding descriptive information about our sample at follow-up, nine 
participants reported they used an electronic nicotine delivery system during the past week, 
with the mean number of use days being 4.33 (SD = 2.40). Number of days participants used 
an electronic nicotine delivery system did not differ by condition (Table 4). Seven 
participants endorsed having used methods other than those provided in the context of the 
study to help them quit smoking (e.g., nicotine gum). Conditions did not significantly differ 
on the number of participants who endorsed having used additional methods during the 
follow-up period (Table 4). Three participants in the hatha yoga condition reported using 
yoga other than that provided by the study during the follow-up period. Six participants in the 
wellness control condition reported reading wellness materials other than participants 
provided by the study during the follow-up period.  
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Table 4. Follow-Up Characteristics of Sample by Condition 
 Total (N = 51) Yoga (n = 25) Control (n = 26) F or 
2 
p d or 
Cramer’s V 
DASS-21 total 23.00 (18.12) 19.00 (12.26) 26.69 (21.81) 2.31 .135 0.43 
DASS-21 depression 6.68 (7.67) 5.00 (5.18) 8.23 (9.25) 2.27 .138 0.43 
DASS-21 anxiety 5.28 (5.87) 4.33 (4.82) 6.15 (6.67) 1.21 .277 0.31 
DASS-21 stress 9.52 (6.60) 8.50 (5.45) 10.46 (7.49) 1.11 .298 0.30 
Minutes accessed materials 102.96 (82.69) 136.68 (79.28) 69.24 (72.84) 9.81 .003 0.89 
Days accessed materials 4.63 (2.48) 5.52 (1.96) 3.77 (2.66) 7.12 .010 0.75 
Use of additional methods (%) 13.73 8.00 19.23 1.36 .244 0.16 
Electronic nicotine use (%) 17.65 12.00 23.08 1.08 .300 0.15 
Past-week cannabis use (%) 19.61 20.00 19.23 0.01 .945 0.01 
Past-week alcohol use (%) 52.94 44.00 61.54 1.57 .210 0.18 





Acute Impact of Condition on Craving and the Role of Anxiety/Depression 
 Consistent with prediction, the hatha yoga condition was significantly associated with 
less post-intervention craving (M = 3.40, SD = 2.10) than the control condition (M = 4.83, SD 
= 1.84), F(1, 53) = 7.27, p = .009, d = 0.72. Contrary to hypothesis, anxiety/depression 
symptoms did not moderate this relationship (Table 5).3 Condition remained significantly 
associated with post-intervention craving after accounting for the variance attributable to pre-
intervention craving and anxiety/depression (Table 5).  
Table 5. Hierarchical Linear Regression of the Condition x Anxiety/Depression Interaction 
on Post-Intervention Craving 
 ΔR2 ΔF B t p sr2 
Step 1 .51 55.32   < .001  
   Baseline craving   0.91 7.44 < .001 .51 
Step 2 .06 3.50   .038  
   Anxiety/depression   0.01 0.49 .625 .00 
   Condition   -1.00 -2.60 .012 .06 
Step 3 .01 0.53   .469  
   Condition x Anxiety/Depression   -0.02 -0.73 .469 .00 
Note. B = unstandardized coefficient; sr2 = squared part (i.e., semipartial) correlations.  
 
Impact of Condition on Follow-up Smoking and the Role of Anxiety/Depression 
Contrary to hypothesis, participants in the hatha yoga condition (M = 4.19, SD = 4.08) 
did not report smoking significantly fewer CPD at follow-up than participants in the control 
condition (M = 4.44, SD = 3.77), F(1, 48) = 0.05, p = .823, d = 0.06. Further, 
anxiety/depression did not moderate this relationship (Table 6).3 Also counter to prediction, 
participants in the hatha yoga condition did not evidence increased odds of attaining seven-
day PPA compared to the control condition (12.5 % vs. 16.00%, respectively), OR = 0.75, 





Table 6. Hierarchical Linear Regression of the Condition x Anxiety/Depression Interaction 
on Follow-Up Cigarettes per Day 
 ΔR2 ΔF B t p sr2 
Step 1 .20 11.90   .001  
   Baseline cigarettes per day   0.32 3.45 .001 .20 
Step 2 .01 0.32   .726  
   Anxiety/depression    -0.01 -0.43 .673 .00 
   Condition   0.65 0.65 .519 .01 
Step 3 .01 0.50   .483  
   Condition x Anxiety/Depression   -0.04 -0.71 .483 .01 
Acute Impact of Condition on Transdiagnostic Factors and the Role of 
Anxiety/Depression 
 Contrary to prediction, the hatha yoga condition (M = 14.83, SD = 11.35) did not 
evidence significantly less post-intervention AS than the control condition (M = 18.10, SD = 
13.40), F(1, 52) = 0.91, p = .346, d = 0.26. Further, anxiety/depression symptoms did not 
moderate this relationship (Table 7).3 Similarly, the hatha yoga condition (M = 3.46, SD = 
1.03) was not significantly associated with greater post-intervention perceived DT compared 
to the control condition (M = 3.10, SD = 0.97), F(1, 53) = 1.83, p = .182, d = 0.36, and 
anxiety/depression did not moderate this relationship (Table 8).3 Contrary to hypothesis, the 
hatha yoga condition (M = 41.50, SD= 19.32) was not associated with greater post-
intervention BH than the wellness control condition (M = 47.41, SD = 21.66), F(1, 52) = 
1.10, p = .298, d = 0.29, nor did anxiety/depression moderate this relationship (Table 9).3  
Table 7. Hierarchical Linear Regression of the Condition x Anxiety/Depression Interaction 
on Post-Intervention Anxiety Sensitivity  
 ΔR2 ΔF B t p sr2 
Step 1 .81 220.63   < .001  
   Baseline anxiety sensitivity   0.89 14.85 < .001 .81 
Step 2 .04 5.97   .005  
   Anxiety/depression   0.14 3.28 .002 .03 
   Condition   1.80 1.27 .212 .00 
Step 3 .00 0.40   .528  
   Condition x Anxiety/Depression   -0.05 -0.64 .528 .00 
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Table 8. Hierarchical Linear Regression of the Condition x Anxiety/Depression Interaction 
on Post-Intervention Perceived Distress Tolerance 
 ΔR2 ΔF B t p sr2 
Step 1 .89 441.44   < .001  
   Baseline distress tolerance   0.99 21.01 < .001 .89 
Step 2 .01 1.51   .230  
   Anxiety/depression   0.00 -1.61 .114 .01 
   Condition   0.06 0.68 .503 .00 
Step 3 .00 0.16   .688  
   Condition x Anxiety/Depression   0.00 -0.40 .688 .00 
Table 9. Hierarchical Linear Regression of the Condition x Anxiety/Depression Interaction 
on Post-Intervention Breath-Holding 
 ΔR2 ΔF B t p sr2 
Step 1 .80 205.41   < .001  
   Baseline breath-holding   0.92 14.33 < .001 .80 
Step 2 .01 1.77   .181  
   Anxiety/depression   -0.05 -0.79 .433 .00 
   Condition   -4.49 -1.77 .083 .01 
Step 3 .00 0.62   .435  
   Condition x Anxiety/Depression   -0.11 -0.79 .435 .00 
Counter to prediction, the hatha yoga condition (M = 151.16, SD = 146.65) was not 
significantly associated with greater post-intervention PASAT than the control condition (M 
= 188.25, SD = 136.54), F(1, 53) = 0.94, p = .337, d = 0.26, nor did anxiety/depression 
symptoms moderate this relationship (Table 10).3 Similarly, the hatha yoga condition (M = 
17.80, SD = 3.35) was not significantly associated with less post-intervention Anh than the 
wellness control condition (M = 18.52, SD = 4.07), F(1, 52) = 0.49, p = .487, d = 0.19. 
Anxiety/depression symptoms did not moderate this relationship (Table 11).3 
Table 10. Hierarchical Linear Regression of the Condition x Anxiety/Depression Interaction 
on Post-Intervention PASAT 
 ΔR2 ΔF B t p sr2 
Step 1 .77 177.57   < .001  
   Baseline PASAT   0.96 13.33 < .001 .77 
Step 2 .00 0.50   .607  
   Anxiety/depression   0.49 0.99 .325 .00 
       
(Table 10 continued)       
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 ΔR2 ΔF B t p sr2 
   Condition   -1.45 -0.08 .939 .00 
Step 3 .00 0.26   .610  
   Condition x Anxiety/Depression   -0.51 -0.51 .610 .00 
Table 11. Hierarchical Linear Regression of the Condition x Anxiety/Depression Interaction 
on Post-Intervention Anhedonia 
 ΔR2 ΔF B t p sr2 
Step 1 .80 206.33   < .001  
   Baseline anhedonia   0.81 14.36 < .001 .80 
Step 2 .00 0.20   .822  
   Anxiety/depression   0.01 0.62 .535 .00 
   Condition   -0.03 -0.05 .957 .00 
Step 3 .00 0.06   .810  
   Condition x Anxiety/Depression   -0.01 -0.24 .810 .00 
Impact of Condition on Follow-up Transdiagnostic Factors and the Role of 
Anxiety/Depression 
 Consistent with our hypothesis, the hatha yoga condition (M = 11.04, SD = 8.14) was 
significantly associated with less follow-up AS than the wellness control condition (M = 
17.92, SD = 14.39), F(1, 49) = 4.38, p = .042, d = 0.59. Also consistent with prediction, 
anxiety/depression symptoms moderated the relationship between condition and follow-up 
AS (Table 12).3 Baseline AS accounted for 64% of the variance in follow-up AS, the main 
effects of condition and anxiety/depression accounted for an additional 3% of the variance, 
and the Condition x Anxiety/Depression interaction accounted for an additional 6% of unique 
variance.  
Table 12. Hierarchical Linear Regression of the Condition x Anxiety/Depression Interaction 
on Follow-Up Anxiety Sensitivity 
 ΔR2 ΔF B t p sr2 
Step 1 .64 85.63   < .001  
   Baseline anxiety sensitivity   0.72 9.25 < .001 .64 
Step 2 .03 1.81   .175  
   Anxiety/depression   -0.01 -0.15 .883 .00 
   Condition   -3.89 -1.87 .067 .03 
Step 3 .06 10.69   .002  
   Condition x Anxiety/Depression   -0.34 -3.27 .002 .06 
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We examined the form of the significant interaction (Figure 2) and among 
participants with higher anxiety/depression symptoms, the simple slope was significant, B = 
10.07, t = 3.77, p < .001, sr2 = 0.08, indicating that condition was related to follow-up AS, 
such that participants in the hatha yoga condition endorsed lower levels of AS than 
participants in the wellness control condition. Among participants with lower 
anxiety/depression, the simple slope was not significantly different from zero, B = 2.22, t = 
0.84, p = .408, sr2 = 0.00, indicating that condition was not associated with follow-up AS. 
Among participants in the hatha yoga condition, the difference between baseline (M = 22.20, 
SD = 12.75) and follow-up (M = 11.04, SD = 8.14) AS represents a large effect, t(24) = 4.93, 
p < .001, d = 0.86.  
 
 
Figure 2. Significant Condition x Anxiety/Depression interaction predicting follow-up 
anxiety sensitivity  
Contrary to prediction, the hatha yoga condition (M = 3.49, SD = 0.90) was not 
significantly associated with greater follow-up perceived DT than the control condition (M = 
3.19, SD = 0.93), F(1, 49) = 1.28, p = .264, d = 0.32, nor did not anxiety/depression moderate 
this relationship (Table 13).3 Also counter to prediction, the hatha yoga condition (M = 36.04, 






















38.79, SD = 24.62), F(1, 48) = 0.17, p = .682, d = 0.12. Additionally, anxiety/depression did 
not moderate this relationship (Table 14).3 Similarly, the hatha yoga (M = 19.16, SD = 5.17) 
condition was not associated with less follow-up Anh than the control condition (M = 19.62, 
SD = 5.20), F(1, 49) = 0.10, p = .757, d = 0.09, nor did anxiety/depression moderate this 
relationship (Table 15).3 
Table 13. Hierarchical Linear Regression of the Condition x Anxiety/Depression Interaction 
on Follow-Up Perceived Distress Tolerance 
 ΔR2 ΔF B t p sr2 
Step 1 .68 104.34   < .001  
   Baseline distress tolerance   0.78 10.22 < .001 .68 
Step 2 .00 0.02   .985  
   Anxiety/depression   0.00 0.04 .967 .00 
   Condition   0.03 0.16 .872 .00 
Step 3 .01 1.81   .185  
   Condition x Anxiety/Depression   -0.01 -1.35 .185 .01 
Table 14. Hierarchical Linear Regression of the Condition x Anxiety/Depression Interaction 
on Follow-Up Breath-Holding 
 ΔR2 ΔF B t p sr2 
Step 1 .42 34.44   < .001  
   Baseline breath-holding   0.71 5.87 < .001 .42 
Step 2 .02 1.01   .373  
   Anxiety/depression   -0.21 -1.41 .165 .02 
   Condition   -0.70 -0.14 .891 .00 
Step 3 .00 0.04   .845  
   Condition x Anxiety/Depression   -0.06 -0.20 .845 .00 
Table 15. Hierarchical Linear Regression of the Condition x Anxiety/Depression Interaction 
on Follow-Up Anhedonia 
 ΔR2 ΔF B t p sr2 
Step 1 .46 41.19   < .001  
   Baseline anhedonia   0.86 6.42 < .001 .46 
Step 2 .02 1.03   .366  
   Anxiety/depression   0.05 1.42 .162 .02 
   Condition   0.13 0.12 .902 .00 
Step 3 .01 0.52   .476  
   Condition x Anxiety/Depression   -0.04 -0.72 .476 .01 
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Moderating Role of Time Spent Using Intervention Materials 
 Contrary to prediction, number of minutes participants accessed their materials did 
not moderate the relationship between condition and follow-up CPD (Table 16).3 Also 
inconsistent with prediction, number of minutes participants accessed their materials did not 
moderate the relationship between condition and follow-up AS (Table 17).3 Similarly, 
number of minutes participants accessed their materials did not moderate the relationships 
between condition and follow-up perceived DT (Table 18),3 follow-up behavioral DT (i.e., 
BH; Table 19),3 or follow-up Anh (Table 20).3   
Table 16. Hierarchical Linear Regression of the Condition x Minutes Participants Accessed 
Their Materials Interaction on Follow-Up Cigarettes per Day 
 ΔR2 ΔF B t p sr2 
Step 1 .28 18.28   < .001  
   Baseline cigarettes per day   0.40 4.28 < .001 .28 
Step 2 .02 0.75   .478  
   Minutes   -0.01 -1.12 .269 .02 
   Condition   0.93 0.91 .370 .01 
Step 3 .02 1.22   .275  
   Condition x Minutes   0.01 1.11 .275 .02 
Table 17. Hierarchical Linear Regression of the Condition x Minutes Participants Accessed 
Their Materials Interaction on Follow-Up Anxiety Sensitivity 
 ΔR2 ΔF B t p sr2 
Step 1 .64 86.14   < .001  
   Baseline anxiety sensitivity    0.72 9.28 < .001 .64 
Step 2 .03 2.29   .113  
   Minutes   0.01 0.47 .641 .00 
   Condition   -4.74 -2.09 .042 .03 
Step 3 .00 0.12   .726  
   Condition x Minutes   -0.01 -0.35 .726 .00 
Table 18. Hierarchical Linear Regression of the Condition x Minutes Participants Accessed 
Their Materials Interaction on Follow-Up Perceived Distress Tolerance 
 ΔR2 ΔF B t p sr2 
Step 1 .68 104.34   < .001  
   Baseline distress tolerance    0.78 10.22 < .001 .68 
       
(Table 18 continued)       
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 ΔR2 ΔF B t p sr2 
Step 2 .00 0.02   .986  
   Minutes   0.00 -0.04 .970 .00 
   Condition   0.03 0.17 .866 .00 
Step 3 .00 0.23   .631  
   Condition x Minutes   0.00 -0.48 .631 .00 
Table 19. Hierarchical Linear Regression of the Condition x Minutes Participants Accessed 
Their Materials Interaction on Follow-Up Breath-Holding 
 ΔR2 ΔF B t p sr2 
Step 1 .40 31.40   < .001  
   Baseline breath-holding    0.75 5.60 < .001 .40 
Step 2 .00 0.04   .961  
   Minutes   -0.01 -0.13 .894 .00 
   Condition   -0.98 -0.17 .868 .00 
Step 3 .00 0.08   .775  
   Condition x Minutes   0.02 0.29 .775 .00 
Table 20. Hierarchical Linear Regression of the Condition x Minutes Participants Accessed 
Their Materials Interaction on Follow-Up Anhedonia 
 ΔR2 ΔF B t p sr2 
Step 1 .45 39.57   < .001  
   Baseline anhedonia    0.85 6.29 < .001 .45 
Step 2 .02 0.65   .527  
   Minutes   -0.01 -1.14 .262 .01 
   Condition   0.70 0.57 .573 .01 
Step 3 .00 0.04   .843  
   Condition x Minutes   0.00 0.20 .843 .00 
Mediating Role of Transdiagnostic Factors  
 As described above, condition was not associated with post-intervention AS, 
perceived DT, behavioral DT, or Anh. Thus, the mediating role of these transdiagnostic 
factors in the relationship between condition and post-intervention craving was not tested. 
Given that condition was associated with follow-up AS, but not follow-up perceived DT, 
behavioral DT, or Anh (as described above), we tested the direct and indirect effects of 
condition on follow-up CPD through follow-up AS (Table 21).3 The total effect model (with 
condition and covariates as independent variables) did not account for significant variance in 
follow-up CPD, though baseline CPD did account for significant variance. The full model, 
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including follow-up AS, also did not account for significant variance in follow-up CPD. The 
direct effect of condition on follow-up CPD (controlling for covariates and follow-up AS) 
was not significant. The indirect effect of condition on follow-up CPD craving via follow-up 
AS was also nonsignificant (Figure 3). 
Table 21. Direct and Indirect Effects of Condition on Follow-Up Cigarettes per Day via 
Follow-Up Anxiety Sensitivity  
 R2 F B t p 95% CI 
Total effect model .22 1.51   .224  
   Condition    0.47 0.46 .645 [-1.56, 2.50] 
   Baseline cigarettes per day   0.34 2.11 .041 [0.01, 0.66] 
   Baseline AS    -0.03 -0.93 .358 [-0.10, 0.04] 
Full model .23 1.22   .318  
   Condition    0.35 0.27 .786 [-2.22, 2.92] 
   Baseline cigarettes per day   0.34 1.91 .062 [-0.02, 0.70] 
   Baseline AS    0.01 0.05 .961 [-0.26, 0.27] 
   Follow-up AS   -0.05 -0.37 .711 [-0.32, 0.22] 
Direct effect   0.35 0.27 .786 [-2.22, 2.92] 
Indirect effect       
   Follow-up AS   0.03   [-0.12, 0.36] 
 
 
Figure 3. Direct and indirect effects of condition on follow-up cigarettes per day via follow-





 The current study tested whether hatha yoga (versus a wellness control condition) 
reduced craving acutely and aided in smoking reduction or cessation over the course of one 
week. The current study also tested whether the presence of anxiety/depression symptoms 
impacted the utility of hatha yoga for reducing craving and smoking. Additionally, informed 
by a recent theoretical model that proposed that anxiety/depression symptoms are linked to 
smoking-related risk factors and poorer smoking cessation outcomes via transdiagnostic 
reactive factors, AS, DT, and Anh (Leventhal & Zvolensky, 2015), we tested whether hatha 
yoga impacted AS, DT, and Anh and whether these factors mediated the relationship between 
condition and smoking-related outcomes.  
Consistent with our hypothesis and prior research finding that hatha yoga reduced 
craving among nicotine-deprived smokers not attempting to change their smoking (Elibero et 
al., 2011), on intervention day, hatha yoga was associated with less craving than the control 
condition, even after accounting for the variance attributable to participants’ baseline craving. 
Yet, anxiety/depression did not moderate the relationship between condition and post-
intervention craving. These results suggest hatha yoga is associated with a reduction in 
craving among smokers attempting to reduce or quit smoking, regardless of whether they 
have elevated anxiety/depression symptoms.  
Our results do not support the hypothesis that hatha yoga exerts its effects on 
smoking-related factors through changes in AS, DT, or Anh. In light of our sample endorsing 
relatively low levels of anxiety/depression, and consistent with Leventhal and Zvolensky’s 
model (2015), it is possible that hatha yoga impacts smoking outcomes through these 
transdiagnostic factors among smokers with clinical levels of anxiety/depression, as these 
individuals would also likely have higher levels of AS (e.g., Otto et al., 1995; Taylor et al., 
2007) and Anh (e.g., Kashdan, 2004; Lewinsohn, 1974), and lower DT (e.g., Keough et al., 
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2010; Williams et al., 2013). It is also possible that hatha yoga impacts smoking outcomes 
through other mechanisms, such as smoking-specific self-efficacy (i.e., one’s confidence in 
ability to quit smoking; Loprinzi, Wolfe, & Walker, 2015). Exercise, including hatha yoga, 
may expand individuals’ abilities to cope with craving, leading them to feel more efficacious 
in abstaining from smoking. In support of hatha yoga potentially being related to smoking 
outcomes through smoking-specific self-efficacy, Mindfulness-Based Addiction Treatment 
(versus usual care) was associated with increases in smoking-specific self-efficacy and 
increases in smoking-specific self-efficacy mediated the relationship between condition and 
abstinence four weeks post-quit (Spears et al., 2017).  
Hatha yoga was not associated with less smoking at follow-up relative to control. 
These findings are in contrast to prior work finding that hatha yoga was efficacious as an aid 
to CBT for smoking cessation (Bock et al., 2012). These findings are also inconsistent with 
findings of a study evaluating the efficacy of a brief mindfulness-based intervention on 
craving and seven-day follow-up smoking (Bowen & Marlatt, 2009). However, participants 
in that study were taught a different mindfulness technique (urge surfing) in response to 
smoking cues, whereas we did not tell participants to use hatha yoga in response to smoking 
cues or to help manage craving. Another possible explanation for this discrepancy is that 
participants in Bowen and Marlatt’s study smoked fewer CPD and had less severe nicotine 
dependence than participants in our study, suggesting brief, mindfulness-based interventions 
may only be efficacious for very low-level smokers. When considered with Elibero and 
colleagues’ study (2011), our results suggest hatha yoga is helpful for reducing craving 
among smokers attempting to reduce or quit smoking but is not an efficacious stand-alone 
intervention for smoking reduction or cessation, at least in the short-term. An important next 
step in this line of research will be to test whether encouraging individuals to use hatha yoga 
in response to smoking cues (including craving) reduces craving and CPD more long-term. 
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Further, future research is necessary to test whether hatha yoga could aid in smoking 
reduction or cessation among smokers with clinical levels of anxiety/depression.  
In contrast to previous research (for review see Leventhal & Zvolensky, 2015), AS, 
DT, and Anh were not associated with CPD in the current study. Again, differences in 
smoking rates may account for these discrepant findings given that smokers in the current 
study generally smoked fewer CPD than participants in studies finding these relationships. It 
is also possible that these factors are more strongly related to smoking among those with 
clinically elevated symptoms (e.g., Brown et al., 2001; Cook et al., 2010).  
 Notably, the hatha yoga condition was associated with reduced AS compared to the 
control condition at follow-up, especially among participants with higher anxiety/depression. 
Number of minutes participants accessed their materials during the follow-up period did not 
moderate the relationship between condition and follow-up AS. However, on average, 
participants in the hatha yoga condition reported practicing hatha yoga on more than five 
days during the follow-up period, suggesting AS may be malleable in response to repeated 
hatha yoga practice. This finding is in line with emotional processing theory (Foa & Kozak, 
1986), such that hatha yoga may decrease AS via repeated exposure to anxiety-related 
symptoms produced by hatha yoga, thereby promoting habituation to these symptoms. This 
finding is also consistent with the mindfulness component of hatha yoga, which teaches 
individuals to focus on present moment experiences, such as anxiety-related sensations (e.g., 
increased heart rate) produced by hatha yoga, in a nonjudgmental and curious way, thereby 
promoting acceptance of these sensations (Kabat-Zinn, 2003). Importantly, the difference 
between baseline and follow-up AS among participants in the hatha yoga condition in our 
study represents a large effect. Not only is AS implicated in the etiology and maintenance of 
smoking (Leventhal & Zvolensky, 2015), it is also a risk factor for developing Axis I 
psychopathology (e.g., anxiety and depressive disorders; Schmidt, Zvolensky, & Maner, 
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2006). Thus, hatha yoga may serve as an additional tool for prevention and intervention 
efforts for individuals with high AS. 
Contrary to hypothesis, and prior work demonstrating that a single bout of exercise 
acutely reduced AS (Broman-Fulks et al., 2015; LeBouthillier & Asmundson, 2015), one 
session of hatha yoga did not acutely reduce AS in the current study. This discrepant finding 
could be accounted for by differences in participants’ baseline AS between studies. To 
illustrate, participants in past studies that demonstrated acute reductions in AS from one bout 
of exercise (Broman-Fulks et al., 2015; LeBouthillier & Asmundson, 2015) endorsed lower 
levels of AS than participants in the current study. Thus, AS may be more acutely malleable 
via exercise among individuals with lower AS compared to individuals with higher AS. 
Current study findings suggest that hatha yoga does not impact perceived DT acutely 
or over the course of one week, even with continued practice. This finding is consistent with 
prior research finding that neither aerobic exercise nor resistance training increased DT 
acutely (e.g., Broman-Fulks et al., 2015). Consistent with prior work indicating hatha yoga 
increased DT over the course of eight weeks (Medina et al., 2015), it is likely that hatha yoga 
is unable to impact DT in the short-term but continued practice of hatha yoga over the course 
of several weeks may increase DT. Although prior research has not examined whether hatha 
yoga impacts behavioral DT, our finding that hatha yoga does not acutely affect behavioral 
DT is consistent with the finding that perceived DT is not acutely impacted by other forms of 
exercise (e.g., Broman-Fulks et al., 2015). Similarly, our findings suggest that hatha yoga 
does not impact Anh acutely or over the course of one week. Similar to prior research 
concerning perceived DT (Medina et al., 2015), it may be that hatha yoga would reduce Anh 
over the course of several weeks or months with continued practice.  
Our findings also demonstrated that participants continued practicing hatha yoga 
during the follow-up period using the instructional video they followed during their 
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intervention day appointment. On average, participants practiced hatha yoga on 5.5 days 
during the week following their intervention day. This finding is in contrast to findings from 
a study evaluating the efficacy of yogic breathing on smoking craving among abstinent 
smokers, which found that adherence to utilization of yogic breathing to cope with craving 
during the 24 hours following the laboratory appointment was low (Shahab, Sarkar, & West, 
2013). These discrepant findings are likely due to participants in the current study desiring to 
reduce or quit smoking, whereas participants in Shahab and colleagues’ study were not 
attempting to change their smoking. In contrast to Shahab and colleagues’ study, participants 
in the current study were provided a video to aid them in continued practice of hatha yoga, 
which may have also contributed to greater adherence in the present study. Although 
participants in the hatha yoga condition did not report smoking less at follow-up than 
participants in the control condition, their continued use of hatha yoga during the follow-up 
period is meaningful given that hatha yoga is associated with numerous physical (e.g., 
improved strength; for review see Raub, 2002) and mental health (e.g., decreased anxiety and 
depression; for reviews see Hofmann et al., 2016; Uebelacker, Epstein-Lubow, et al., 2010) 
benefits.  
Limitations and Future Directions 
 Study findings should be considered in light of the study’s limitations. First, the 
sample comprised relatively light smokers compared to prior smoking cessation studies (e.g., 
Bock et al., 2012). Second, despite using advertisements to oversample for individuals with 
elevated anxiety/depression, on average, our participants endorsed depression within the 
normal range and anxiety within the mild range (Antony et al., 1998). Further, non-
completers (i.e., participants who did not complete follow-up) endorsed more severe 
anxiety/depression symptoms than completers. Although this group difference was not 
statistically significant, it represented a medium effect size, suggesting clinical significance. 
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Thus, our participants generally did not resemble a clinical sample, suggesting they may not 
have faced the same barriers to smoking cessation as clinical samples, and participants who 
did endorse higher levels of anxiety/depression symptoms were more likely to drop out of the 
study. Future work would benefit from testing the utility of hatha yoga in smoking cessation 
among heavier smokers with higher levels of anxiety/depression symptoms as well as 
strategies to improve retention rates among these smokers. Third, follow-up smoking was 
assessed via self-report, and though prior studies evaluating brief interventions for smoking 
have assessed follow-up smoking via self-report (e.g., Bowen & Marlatt, 2009), and in our 
sample, baseline self-reported smoking was moderately correlated with biochemical 
verification of smoking status, future work would benefit from assessing follow-up smoking 
outcomes using multiple methods (e.g., self-report, CO analyses of breath samples, saliva 
cotinine levels).  
Fourth, we chose a relatively short follow-up period (i.e., one week) given that the 
majority of smokers who underwent an unaided quit attempt smoked within the first week 
(Langdon, Farris, Øverup, et al., 2016). However, in light of our findings that hatha yoga 
reduced AS, a risk factor for poorer smoking cessation outcomes (Assayag et al., 2012; 
Brown et al., 2001; Zvolensky et al., 2009), future research is necessary to test whether hatha 
yoga is a more useful intervention tool for smoking reduction and cessation over longer 
follow-up periods. Additionally, future work would benefit from continued study of the 
mechanisms by which hatha yoga exerts its effects on smoking outcomes (e.g., smoking-
specific self-efficacy).  
Fifth, although changes in AS from baseline to follow-up among participants in the 
hatha yoga condition represent a large effect, it remains unknown whether hatha yoga would 
benefit individuals with higher levels of AS as efficaciously as aerobic exercise (e.g., 
Broman-Fulks & Storey, 2008). Thus, testing the efficacy of hatha yoga for reducing AS in 
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comparison to other forms of exercise among individuals with higher levels of AS is an 
important future direction. Sixth, participants who were deemed possibly unable to safely 
engage in exercise (e.g., for having "heart troubles"; Chisholm et al., 1975) were excluded 
from the current study. Although this precaution was taken to avoid potentially harming 
study participants, it is unknown whether results of the current study would generalize to 
smokers who have medical comorbidities, such as cardiovascular disease, respiratory disease, 
or cancer (Centers for Disease Control and Prevention, 2017a).  
Conclusions 
 Results from the current study suggest that hatha yoga on its own is not a sufficient 
intervention to aid individuals in reducing smoking, at least in the short-term. Yet, hatha yoga 
may serve as a useful tool to help acutely curb cravings among smokers attempting to reduce 
or quit smoking. Anxiety/depression symptoms did not impact the relationship between 
condition and post-intervention craving, suggesting that hatha yoga is efficacious for acutely 
reducing craving, regardless of whether elevated anxiety/depression symptoms are present. 
Future research is necessary to test whether clinical levels of anxiety/depression symptoms 
would impact these relationships. Given poor smoking cessation outcomes among those with 
clinically elevated anxiety/depression symptoms (Hitsman et al., 2013; Piper et al., 2010; 
Zvolensky et al., 2009), such research could have important implications for prevention and 




1Reasons for being unable to safely engage in exercise at screening included: often 
feeling faint or having spells of severe dizziness (n = 42), having high blood pressure (n = 
40), having chest pains (n = 38), having heart trouble (n = 27), having a bone or joint 
problem that could be exacerbated by exercise (n = 11), and other physical reasons (n = 4).  
 2The majority of participants (51.2%) who were excluded for smoking less than five 
cigarettes per day were recruited from the university’s psychology participant pool.  
3Given that study conditions did not significantly differ on any theoretically relevant 
variables at baseline, we also conducted study analyses without covariates. Patterns of 
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